Finance

Lists
Why is 4594 down 4,44%?
Dive Deeper
4594:TYO
BrightPath Biotherapeutics Co Ltd
43,00 JP¥
-4,44%
(-2,00) 1D
8 қаз., 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4594...
Open
45 JP¥
High
45 JP¥
Low
42 JP¥
Mkt. cap
6,23 млрд
Avg. vol.
1,55 млн
Volume
2,60 млн
52-wk high
96 JP¥
52-wk low
42 JP¥
EPS
-13 JP¥
Shares outstanding
41,98 млн
No. of employees
23
Open
45 JP¥
High
45 JP¥
Low
42 JP¥
Mkt. cap
6,23 млрд
Avg. vol.
1,55 млн
Volume
2,60 млн
52-wk high
96 JP¥
52-wk low
42 JP¥
EPS
-13 JP¥
Shares outstanding
41,98 млн
No. of employees
23
News stories
From web sources and news partners
About BrightPath Biotherapeutics Co Ltd
CEO-
Employees23
Founded2003 ж. 08 мам.
Headquarters-
Sector-
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025 ж. мау.
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
Revenue
16,50 мың
16,50 мың
-
51,00 мың
Cost of goods sold
4,00 мың
4,00 мың
-
21,00 мың
Cost of revenue
4,00 мың
4,00 мың
-
21,00 мың
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
232,30 млн
232,30 млн
492,02 млн
338,44 млн
Operating expense
232,30 млн
232,30 млн
492,02 млн
338,44 млн
Total operating expenses
232,30 млн
232,30 млн
492,02 млн
338,46 млн
Operating income
-232,29 млн
-232,29 млн
-492,02 млн
-338,41 млн
Other non operating income
2,39 млн
2,39 млн
4,27 млн
-18,95 млн
EBT including unusual items
-230,76 млн
-230,76 млн
-491,75 млн
-349,25 млн
EBT excluding unusual items
-230,47 млн
-230,47 млн
-491,75 млн
-358,87 млн
Income tax expense
605,00 м.
605,00 м.
605,00 м.
605,00 м.
Effective tax rate
-0,26%
-0,26%
-0,12%
-0,17%
Other operating expenses
-
-
-
-
Net income
-231,37 млн
-231,37 млн
-492,36 млн
-349,86 млн
Net profit margin
-1 402 233,33%
-1 402 233,33%
-
-685 998,04%
Earnings per share
-
-
-
-
Interest and investment income
6,00 мың
6,00 мың
-
4,00 мың
Interest expense
-
-
-
-
Net interest expenses
6,00 мың
6,00 мың
-
4,00 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары